7.12
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Skeletal muscle relaxants can target the central nervous system [CNS]to reduce muscle tension or act directly at the neuromuscular junction to induce…
Skeletal muscle relaxants reduce muscle tension and induce temporary paralysis to relieve pain.
They are classified into centrally acting muscle relaxants, which affect the central nervous system or CNS, and peripherally or directly acting muscle relaxants, which act directly at the neuromuscular junction.
These drugs differ in their mechanism of action, administration mode and clinical uses.
Centrally acting muscle relaxants inhibit postsynaptic transmission in the CNS and decrease muscle tone.
In contrast, peripherally acting relaxants block neuromuscular transmission in skeletal muscles, reducing muscle contraction and causing muscle paralysis. They have no notable effect on the CNS.
Centrally acting relaxants are generally administered orally, with some being given intravenously and intramuscularly. These treat chronic back pain and fibromyalgia.
Peripherally acting relaxants are administered intravenously to relax muscles during surgeries or short medical procedures.
View the full transcript and gain access to JoVE Core videos
Q1: What is the main difference between centrally and peripherally acting muscle relaxants?
Centrally acting muscle relaxants inhibit postsynaptic transmission in the central nervous system to decrease muscle tone, while peripherally acting relaxants block neuromuscular transmission directly at the neuromuscular junction, reducing muscle contraction and causing paralysis. Centrally acting drugs have notable CNS effects, whereas peripherally acting drugs do not affect the CNS.
Q2: How are centrally acting muscle relaxants administered and what conditions do they treat?
Centrally acting muscle relaxants are generally administered orally, with some given intravenously or intramuscularly. They treat chronic back pain, fibromyalgia, and severe spasms caused by multiple sclerosis, cerebral palsy, stroke, and spinal cord injuries. Their duration of action typically ranges from 5 to 24 hours depending on the specific drug.
Q3: What are the two subclasses of centrally acting muscle relaxants?
Centrally acting muscle relaxants are divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs like baclofen, diazepam, and tizanidine have a duration of 5 to 24 hours. Antispasmodic drugs like cyclobenzaprine have shorter durations of 4 to 6 hours and produce strong antimuscarinic effects such as constipation and urinary retention.
Q4: How do peripherally acting muscle relaxants work and when are they used?
Peripherally acting relaxants block neuromuscular transmission at the neuromuscular junction, reducing muscle contraction and inducing temporary paralysis without affecting the CNS. They are administered intravenously to relax muscles during surgeries or short medical procedures. These drugs are given alongside anesthetics to prolong muscle relaxation during operations.
Q5: What are the two main types of peripherally acting muscle relaxants?
Peripherally acting drugs are classified into neuromuscular blockers and directly acting agents. Neuromuscular blockers like succinylcholine and rocuronium are administered intravenously with durations of 5 to 60 minutes. Directly acting relaxants like dantrolene and botulinum toxin are given intramuscularly or orally with durations ranging from 4 hours to 2 months.
Q6: What side effects can result from using centrally acting muscle relaxants?
Centrally acting muscle relaxants may cause sedation, weakness, and hypotension. Upon discontinuing the medication, patients may experience rebound spasticity. Antispasmodic drugs specifically produce antimuscarinic effects including constipation, bradycardia, and urinary retention, which can limit their use in certain patient populations.
Q7: What adverse effects are associated with peripherally acting muscle relaxants?
Peripherally acting muscle relaxants can cause hypotension, prolonged apnea, increased intraocular pressure, and postoperative muscle pain. Directly acting agents like dantrolene and botulinum toxin weaken muscle contraction, leading to flaccid paralysis. These side effects require careful monitoring during and after administration.